MedPath

Furosemide

Generic Name
Furosemide
Brand Names
Furoscix, Lasix
Drug Type
Small Molecule
Chemical Formula
C12H11ClN2O5S
CAS Number
54-31-9
Unique Ingredient Identifier
7LXU5N7ZO5

Overview

Furosemide is a potent loop diuretic that acts on the kidneys to ultimately increase water loss from the body. It is an anthranilic acid derivative. Furosemide is used for edema secondary to various clinical conditions, such as congestive heart failure exacerbation, liver failure, renal failure, and high blood pressure. It mainly works by inhibiting electrolyte reabsorption from the kidneys and enhancing the excretion of water from the body. Furosemide has a fast onset and short duration of action and has been used safely and effectively in both pediatric and adult patients. The use of furosemide is particularly beneficial in clinical settings that require a drug with a higher diuretic potential. In addition to oral formulations, the solution for intravenous and intramuscular administration is also available, which is typically limited to patients who are unable to take oral medication or for patients in emergency clinical situations.

Background

Furosemide is a potent loop diuretic that acts on the kidneys to ultimately increase water loss from the body. It is an anthranilic acid derivative. Furosemide is used for edema secondary to various clinical conditions, such as congestive heart failure exacerbation, liver failure, renal failure, and high blood pressure. It mainly works by inhibiting electrolyte reabsorption from the kidneys and enhancing the excretion of water from the body. Furosemide has a fast onset and short duration of action and has been used safely and effectively in both pediatric and adult patients. The use of furosemide is particularly beneficial in clinical settings that require a drug with a higher diuretic potential. In addition to oral formulations, the solution for intravenous and intramuscular administration is also available, which is typically limited to patients who are unable to take oral medication or for patients in emergency clinical situations.

Indication

Furosemide is indicated for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome, in adults and pediatric patients. Oral furosemide is indicated alone for the management of mild to moderate hypertension or severe hypertension in combination with other antihypertensive medications. Intravenous furosemide is indicated as adjunctive therapy in acute pulmonary edema when a rapid onset of diuresis is desired. Subcutaneous furosemide is indicated for the treatment of congestion due to fluid overload in adults with NYHA Class II/III chronic heart failure. This drug formulation is not indicated for emergency situations or in patients with acute pulmonary edema.

Associated Conditions

  • Acute Pulmonary Edema
  • Ascites
  • Body Fluid Retention
  • Edema
  • Hypertension
  • Mild to Moderate Hypertension
  • Chest congestion

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/04/23
Phase 3
Not yet recruiting
Stacy Johnson
2025/03/27
Phase 3
Not yet recruiting
2025/03/27
Phase 1
Recruiting
2025/02/12
Early Phase 1
ENROLLING_BY_INVITATION
2025/01/22
Not Applicable
ENROLLING_BY_INVITATION
2024/07/17
Phase 1
Completed
2024/06/21
Not Applicable
Recruiting
National Aeronautics and Space Administration (NASA)
2024/06/04
Phase 4
Not yet recruiting
2024/05/09
Phase 3
Not yet recruiting
2024/03/22
Phase 2
Not yet recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Baxter Healthcare Corporation
36000-064
INTRAVENOUS
10 mg in 1 mL
10/27/2018
A-S Medication Solutions
50090-6219
ORAL
20 mg in 1 1
7/14/2017
Physicians Total Care, Inc.
54868-2299
INTRAVENOUS
10 mg in 1 mL
3/1/2012
State of Florida DOH Central Pharmacy
53808-0367
ORAL
20 mg in 1 1
6/2/2010
RedPharm Drug, Inc.
67296-0691
ORAL
20 mg in 1 1
1/13/2021
Bryant Ranch Prepack
63629-1120
ORAL
80 mg in 1 1
7/30/2020
NorthStar Rx LLC
72603-133
INTRAVENOUS
10 mg in 1 mL
12/27/2022
A-S Medication Solutions
50090-2560
ORAL
20 mg in 1 1
6/28/2018
Major Pharmaceuticals
0904-7178
ORAL
40 mg in 1 1
12/30/2021
Aphena Pharma Solutions - Tennessee, LLC
71610-284
ORAL
20 mg in 1 1
5/30/2019

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
APO-FUROSEMIDE TABLET 40 mg
SIN00088P
TABLET
40 mg
3/14/1988
FUROSEMIDE-AFT SOLUTION FOR INJECTION 20MG/2ML
SIN16784P
INJECTION, SOLUTION
20mg/2ml
5/16/2023
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 20 MG/2 ML
SIN15366P
INJECTION, SOLUTION
20 mg/2 mL
11/23/2017
RASITOL TABLET 40MG
SIN14074P
TABLET
40mg
1/9/2012
DIRINE INJECTION 20 mg/2 ml
ATLANTIC LABORATORIES CORPN LTD
SIN00239P
INJECTION
20 mg/2 ml
4/5/1988
FUROSEMIDE-BAXTER SOLUTION FOR INJECTION 50 MG/5 ML
SIN15365P
INJECTION, SOLUTION
50 mg/5 mL
11/23/2017
FUSETIC SOLUTION FOR INJECTION 20MG/2ML
SIN16712P
INJECTION, SOLUTION
20mg/2ml
2/23/2023
LASIX TABLET 40 mg
SIN00199P
TABLET
40.00 mg
3/28/1988
FUROSEMIDE FRESENIUS KABI SOLUTION FOR INJECTION 20MG/2ML
SIN15131P
INJECTION, SOLUTION
20mg/2ml
12/7/2016
FURMIDE TABLETS 40 mg
SIN00064P
TABLET
40.00 mg
2/24/1988

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Furosemide Tablets
国药准字H62020258
化学药品
片剂
4/10/2020
Furosemide Tablets
国药准字H51022778
化学药品
片剂
8/5/2020
Furosemide for Injection
国药准字H20070276
化学药品
注射剂
3/28/2022
Furosemide for Injection
国药准字H20060659
化学药品
注射剂
7/3/2020
Furosemide for Injection
国药准字H20051479
化学药品
注射剂
12/11/2020
Furosemide for Injection
国药准字H20051478
化学药品
注射剂
12/11/2020
Furosemide for Injection
国药准字H20051116
化学药品
注射剂
7/3/2020
Furosemide Tablets
国药准字H12020163
化学药品
片剂
9/25/2020
Furosemide Tablets
国药准字H44021490
化学药品
片剂
3/30/2020
Furosemide Tablets
国药准字H44022268
化学药品
片剂
11/27/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
FUROSEMIDE TABLETS BP 40MG
N/A
N/A
N/A
10/5/2020
FUROSEMIDE-HAMELN SOLUTION FOR INJECTION 20MG/2ML
N/A
mekim ltd
N/A
N/A
5/27/2025
© Copyright 2025. All Rights Reserved by MedPath